Clinical Trials

Showing trials with last updates posted in 2016.

NCT01099904 | COMPLETED | PHASE1
30 Participants

A Study on the Effect of Renal Function on the Pharmacakokinetics of RO5024048 (Parent of Prodrug RO5024048) Following Multiple Oral Dose Administration of RO5024048

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-03-31
Completion: 2010-09-30
Conditions
Healthy Volunteer
Interventions
DRUG
No Results Yet
NCT01096576 | COMPLETED | PHASE1
64 Participants

A Study of Balapiravir in Patients With Dengue Virus Infection

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-07-31
Completion: 2011-04-30
Conditions
Dengue
Interventions
DRUG
No Results Yet
NCT01094756 | COMPLETED | NA
82 Participants

Brain, Obesity, Dopamine and You Study

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-07-31
Completion: 2015-06-30
Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT
No Results Yet
NCT01087151 | COMPLETED | PHASE2
118 Participants

A Study of ABT-263 in Combination With Dose-Intensive Rituximab, or Dose-Intensive Rituximab Alone, in Previously Untreated Patients With B-Cell, Chronic Lymphocytic Leukemia (CLL)

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-08-31
Completion: 2012-06-30
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG
No Results Yet
NCT01086085 | COMPLETED | PHASE4
265 Participants

A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-04-30
Completion: 2013-03-31
Conditions
Hepatitis B, Chronic
Interventions
DRUG
No Results Yet
NCT01077726 | COMPLETED | PHASE2
3 Participants

A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-01-31
Completion: 2010-12-31
Conditions
Breast Cancer
Interventions
DRUG
No Results Yet
NCT01075477 | COMPLETED
151 Participants

An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)

Study Type: OBSERVATIONAL
Last Updated: 2016-11-02
Start Date: 2009-09-30
Completion: 2011-12-31
Conditions
Rheumatoid Arthritis
Interventions
DRUG
No Results Yet
NCT01075464 | COMPLETED | PHASE1
64 Participants

A Study of the Safety and Pharmacology of MEGF0444A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-02-28
Completion: 2013-04-30
Conditions
Solid Cancers
Interventions
DRUG
No Results Yet
NCT01070927 | COMPLETED | PHASE2
7 Participants

An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-01-31
Completion: 2010-08-31
Conditions
Non-Squamous Non-Small Cell Lung Cancer
Interventions
DRUG
No Results Yet
NCT01057667 | COMPLETED | PHASE2
168 Participants

A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-02-28
Completion: 2012-04-30
Conditions
Hepatitis C, Chronic
Interventions
DRUG
No Results Yet
NCT01051011 | TERMINATED | PHASE3
370 Participants

A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-01-31
Completion: 2010-12-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01045083 | COMPLETED | PHASE1
25 Participants

A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-01-31
Completion: 2011-06-30
Conditions
Healthy Volunteer
Interventions
DRUG
No Results Yet
NCT01044017 | COMPLETED | PHASE1
22 Participants

A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-12-31
Completion: 2010-08-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01043029 | COMPLETED | PHASE2
302 Participants

A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-05-31
Completion: 2012-07-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01042769 | COMPLETED | PHASE3
7226 Participants

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-02-28
Completion: 2013-11-30
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01031745 | COMPLETED | PHASE2
120 Participants

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2011-05-31
Completion: 2011-11-30
Conditions
HIV Substance Abuse, Intravenous
Interventions
BEHAVIORAL OTHER
No Results Yet
NCT01018173 | COMPLETED | PHASE3
2118 Participants

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2010-01-31
Completion: 2011-01-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01017302 | COMPLETED | PHASE1
32 Participants

A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-12-31
Completion: 2011-08-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT01015430 | COMPLETED | PHASE2
40 Participants

A Study With RO4917523 in Patients With Fragile X Syndrome

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-11-30
Completion: 2011-01-31
Conditions
Fragile X Syndrome
Interventions
DRUG
No Results Yet
NCT01010438 | COMPLETED
59 Participants

Clinical Evaluation of an Apnea Index for Diagnosis and Screening of Obstructive Sleep Apnea (OSA)

Study Type: OBSERVATIONAL
Last Updated: 2016-11-02
Start Date: 2009-10-31
Completion: 2011-07-31
Conditions
Obstructive Sleep Apnea
No Results Yet
NCT00985374 | TERMINATED | PHASE1
11 Participants

A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-11-30
Completion: 2013-06-30
Conditions
Neoplasms
Interventions
DRUG
No Results Yet
NCT00975182 | COMPLETED | PHASE1
58 Participants

A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-09-30
Completion: 2014-09-30
Conditions
Non-Squamous Non-Small Cell Lung Cancer, Solid Cancers
Interventions
DRUG
No Results Yet
NCT00974584 | COMPLETED | PHASE1
65 Participants

A Study of the Safety and Pharmacology Of PI3-Kinase Inhibitor GDC-0941 In Combination With Either Paclitaxel And Carboplatin (With or Without Bevacizumab) or Pemetrexed, Cisplatin, And Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-10-31
Completion: 2015-03-31
Conditions
Non-Squamous Non-Small Cell Lung Cancer
Interventions
DRUG
No Results Yet
NCT00965653 | COMPLETED | PHASE1
29 Participants

A Study of Subcutaneously Administered Tocilizumab in Patients With Rheumatoid Arthritis

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-08-31
Conditions
Rheumatoid Arthritis
Interventions
DRUG
No Results Yet
NCT00964704 | WITHDRAWN | PHASE2
0 Participants

A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2011-03-31
Completion: 2013-08-31
Conditions
Breast Cancer
Interventions
DRUG
No Results Yet
NCT00963885 | COMPLETED | PHASE2
229 Participants

A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-08-31
Completion: 2012-01-31
Conditions
Hepatitis C, Chronic
Interventions
DRUG
No Results Yet
NCT00961909 | COMPLETED | PHASE1
122 Participants

A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-06-30
Completion: 2010-10-31
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT00940420 | COMPLETED | PHASE4
2695 Participants

A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2002-10-31
Completion: 2009-11-30
Conditions
Hepatitis C, Chronic
Interventions
DRUG
No Results Yet
NCT00940303 | COMPLETED | PHASE2
97 Participants

OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-06-30
Completion: 2014-02-28
Conditions
Colorectal Cancer
Interventions
DRUG
No Results Yet
NCT00933972 | COMPLETED | PHASE1
36 Participants

A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-06-30
Completion: 2010-09-30
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT00930514 | COMPLETED | PHASE1
281 Participants

A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-09-30
Completion: 2013-07-31
Conditions
Lymphoma, Follicular
Interventions
DRUG
No Results Yet
NCT00928330 | COMPLETED | PHASE1
57 Participants

Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-07-31
Completion: 2014-01-31
Conditions
Metastatic Breast Cancer
Interventions
DRUG
No Results Yet
NCT00922610 | COMPLETED | PHASE4
28 Participants

A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-02-28
Completion: 2010-07-31
Conditions
Anemia
Interventions
DRUG
No Results Yet
NCT00909597 | COMPLETED | PHASE3
756 Participants

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-05-31
Completion: 2010-11-30
Conditions
Diabetes Mellitus Type 2
Interventions
DRUG
No Results Yet
NCT00884507 | COMPLETED | PHASE2
389 Participants

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-05-31
Completion: 2010-11-30
Conditions
Alzheimer's Disease
Interventions
DRUG
No Results Yet
NCT00882674 | COMPLETED | PHASE1
8 Participants

A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-07-31
Completion: 2010-12-31
Conditions
Breast Cancer
Interventions
DRUG
No Results Yet
NCT00879203 | COMPLETED
230 Participants

Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)

Study Type: OBSERVATIONAL
Last Updated: 2016-11-02
Start Date: 2008-11-30
Completion: 2013-11-30
Conditions
Type 1 Diabetes Mellitis Cognition
No Results Yet
NCT00876122 | COMPLETED | PHASE1
60 Participants

A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2008-03-31
Completion: 2012-06-30
Conditions
Non-Hodgkin's Lymphoma, Solid Cancers
Interventions
DRUG
No Results Yet
NCT00876109 | COMPLETED | PHASE1
108 Participants

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2007-10-31
Completion: 2012-06-30
Conditions
Solid Cancers
Interventions
DRUG
No Results Yet
NCT00873756 | COMPLETED | PHASE1
23 Participants

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Study Type: INTERVENTIONAL
Last Updated: 2016-11-02
Start Date: 2009-05-31
Completion: 2014-03-31
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page